Poland · Delayed Price · Currency is PLN Bioceltix Statistics
Total Valuation
Bioceltix has a market cap or net worth of PLN 376.19 million. The enterprise value is 319.53 million.
| Market Cap | 376.19M |
| Enterprise Value | 319.53M |
Important Dates
The last earnings date was Wednesday, September 23, 2026.
| Earnings Date | Sep 23, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Bioceltix has 5.53 million shares outstanding. The number of shares has increased by 7.61% in one year.
| Current Share Class | 5.53M |
| Shares Outstanding | 5.53M |
| Shares Change (YoY) | +7.61% |
| Shares Change (QoQ) | n/a |
| Owned by Insiders (%) | 6.61% |
| Owned by Institutions (%) | 22.43% |
| Float | 4.44M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 6.12 |
| P/TBV Ratio | 6.12 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 19.30, with a Debt / Equity ratio of 0.00.
| Current Ratio | 19.30 |
| Quick Ratio | 19.26 |
| Debt / Equity | 0.00 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -212.14 |
Financial Efficiency
Return on equity (ROE) is -39.44% and return on invested capital (ROIC) is -24.58%.
| Return on Equity (ROE) | -39.44% |
| Return on Assets (ROA) | -22.94% |
| Return on Invested Capital (ROIC) | -24.58% |
| Return on Capital Employed (ROCE) | -29.67% |
| Weighted Average Cost of Capital (WACC) | 9.29% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -377,980 |
| Employee Count | 49 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | -34,019 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -27.46% in the last 52 weeks. The beta is 0.91, so Bioceltix's price volatility has been similar to the market average.
| Beta (5Y) | 0.91 |
| 52-Week Price Change | -27.46% |
| 50-Day Moving Average | 77.04 |
| 200-Day Moving Average | 82.31 |
| Relative Strength Index (RSI) | 29.42 |
| Average Volume (20 Days) | 4,404 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | -2.76M |
| Operating Income | -18.59M |
| Pretax Income | -18.56M |
| Net Income | -18.52M |
| EBITDA | -17.91M |
| EBIT | -18.59M |
| Earnings Per Share (EPS) | -3.49 |
Balance Sheet
The company has 56.83 million in cash and 171,406 in debt, with a net cash position of 56.66 million or 10.24 per share.
| Cash & Cash Equivalents | 56.83M |
| Total Debt | 171,406 |
| Net Cash | 56.66M |
| Net Cash Per Share | 10.24 |
| Equity (Book Value) | 62.52M |
| Book Value Per Share | 11.30 |
| Working Capital | 56.01M |
Cash Flow
In the last 12 months, operating cash flow was -18.22 million and capital expenditures -4.06 million, giving a free cash flow of -22.28 million.
| Operating Cash Flow | -18.22M |
| Capital Expenditures | -4.06M |
| Depreciation & Amortization | 676,300 |
| Net Borrowing | -464,635 |
| Free Cash Flow | -22.28M |
| FCF Per Share | -4.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Bioceltix does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -7.61% |
| Shareholder Yield | -7.61% |
| Earnings Yield | -4.84% |
| FCF Yield | -5.82% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 2 |